Systematic review / meta-analysis / 2015
Oat intake significantly reduced HbA1c, fasting blood glucose, total cholesterol, and LDL-C in patients with type 2 diabetes.
A systematic review and meta-analysis of 14 controlled trials and two uncontrolled observational studies assessed the effects of oat intake in diabetic patients. Compared with controls, oat intake significantly reduced HbA1c (MD, -0.42%; 95% CI, -0.61% to -0.23%), fasting blood glucose (MD, -0.39 mmol/L; 95% CI, -0.58 to -0.19 mmol/L), total cholesterol (MD, -0.49 mmol/L; 95% CI, -0.86 to -0.12 mmol/L), and LDL-C (MD, -0.29 mmol/L; 95% CI, -0.48 to -0.09 mmol/L). Oatmeal also significantly reduced acute postprandial glucose and insulin responses compared with control meals. The authors noted that further studies on type 1 diabetes and safety are needed.
- Study type
- Systematic review and meta-analysis
- Who was studied
- Patients with type 2 diabetes across 14 controlled trials and 2 uncontrolled observational studies
- What was measured
- HbA1c, fasting blood glucose, total cholesterol, LDL-C, and acute postprandial glucose and insulin responses
THE PAPER
The Metabolic Effects of Oats Intake in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Hou Q, Li Y, Li L, Cheng G, Sun X, Li S, Tian H. Nutrients, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.